Microbiology News: clinical, Dec 2021

JAVASCRIPT DISABLED - This site works best with JavaScript enabled.

Microbiology News: clinical, Dec 2021

Assay Development Clinical Cosmetic/Personal Care Food & Beverage Laboratory Equipment Microbiome Other Pharmaceutical Veterinary Water

SARS-CoV-2 Mutants Protein Available at Creative Diagnostics

20 Dec 2021 | ClinicalPharmaceutical

Creative Diagnostics has launched a range of SARS-CoV-2 recombinant antigens that can be used to test the efficacy of COVID-19 vaccines, SARS-CoV-2 antibodies and rapid antigen testing. more...

FDA Clears SeptiCyte^® RAPID - The First One-Hour, Direct-from-Blood Sepsis Test

13 Dec 2021 | Clinical

SeptiCyte The First One-Hour Direct-from-Blood Sepsis Test

Fully automated diagnostic tool SeptiCyte® RAPID quantifies the relative expression levels of genes involved in a patient's immune response to infection to aid in a diagnosis in one hour for patients suspected of sepsis. more...

Pharmig's 29th Annual Conference - A rapidmicrobiology Report

10 Dec 2021 | ClinicalPharmaceuticalCosmetic/Personal Care

Pharmaceutical Microbiology interest Group conference report

Highlights from this year's Pharmig Annual Conference. Now in its 29th year, the conference facilitates the discussion on hot topics in the pharma, healthcare, and personal care and cosmetic industries. more...

BIOTECON Diagnostics Confirms its COVID-19 PCR Tests can Detect New Omicron Variant

09 Dec 2021 | Clinical

BIOTECON Diagnostics is pleased to confirm its two CE-IVD certified microproof® SARS-CoV-2 Screening and Identification Kits can detect the new Omicron variant, as well as Alpha and Delta. more...

Alpha Laboratories Wins "Partnership With the NHS" Innovation Award

08 Dec 2021 | Clinical

Alpha Laboratories partnered with the Clinical Biochemistry team at Cwm Taf Morgannwg University Health Board to implement the quantitative Faecal Immunnochemical Test (FIT) which helps identify patients who may have significant colorectal disease. more...

Bruker Confirm COVID-19 Diagnostics Cover Omicron Variant

07 Dec 2021 | Clinical

Bruker Corporation has announced that its established CE-IVD marked FluoroType® SARS-CoV-2 varID Q real-time multiplexed PCR assay reliably detects all SARS-CoV-2 variants. more...

Creative Diagnostics Launches SARS-CoV-2 Pseudovirus Neutralization Assay

07 Dec 2021 | Clinical

Creative Diagnostics has developed a SARS-CoV-2 pseudovirus with HIV lentiviral vector that meets the requirements for SARS-CoV-2 neutralization assays and screening neutralization antibodies or serum. more...

Specific PCR-based Detection of SARS-CoV-2 Including New Variants

06 Dec 2021 | Clinical

The EURORealTime SARS-CoV-2 provides fast and highly specific detection of SARS-CoV-2 including the variants alpha (B.1.1.7), beta (B.1.351), gamma (P.1), delta (B1.617.2), lambda (C.37), mu (B.1.621) and omicron (B.1.1.529). more...

Panel of Research Reagents for SARS-CoV-2 Omicron Variant (B.1.1.529) Launched

06 Dec 2021 | Clinical

Sino Biological, Inc. has launched a panel of research reagents for the newly identified Omicron which has quickly raised concerns around the world because of the high number of mutations it carries, especially the 30-plus mutations on the Spike protein. more...

SARS-CoV-2 Omicron Spike Proteins and Antibodies Available

01 Dec 2021 | Clinical

The nucleocapsid protein is commonly used as the biomarker in rapid antigen tests. It’s critical to assess whether the current commercial antigen tests can detect the mutated N proteins with the same sensitivity and specificity as their WT counterpart. more...

Reducing Cell Culture Contamination with INTEGRA’s Versatile Pipettes

01 Dec 2021 | Clinical

INTEGRA Biosciences supplies a comprehensive range of liquid handling tools that are ideal for sterile cell biology workflows. Each piece of equipment has been expertly designed to fit comfortably under a laminar flow hood to reduce the risk of cell culture contamination. more...